Financial News
Latest News about Briefs
Recent news which mentions Briefs
From Benzinga
AstraZeneca's Combination Cancer Drug For Advanced Breast Cancer Study Flunks Late-Stage Trial
June 18, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Tesla's Chinese Rival NIO Unveils Plans For Nio IN 2024: Anticipates Launch of Second-Generation Nio Phone Amid Innovations
June 18, 2024
From Benzinga
From Benzinga
Asia And Europe Markets Advance, Crude Near $80 While Dollar Gains - Global Markets Today While US Slept
June 18, 2024
From Benzinga
Why Rocket Lab Shares Are Gaining Today
June 18, 2024
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Why Adobe's Shares Are Trading Lower Monday
June 17, 2024
From Benzinga
From Benzinga
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading Claims
June 17, 2024
From Benzinga
From Benzinga
Why Xponential Fitness Shares Are Surging On Monday
June 17, 2024
From Benzinga
Detailed Data From Gilead Halted Blood Cancer Drug Magrolimab Program Shows Higher Deaths And Side Effects
June 17, 2024
From Benzinga
From Benzinga
From Benzinga
What's Happening With US Steel Shares On Monday?
June 17, 2024
From Benzinga
Mirum Pharmaceuticals Highlights Encouraging Data For Rare Liver Disease Therapy From Two Mid-Stage Studies
June 17, 2024
From Benzinga
From Benzinga
Why Is Small Cap-Heart Disease Focused Aerovate Therapeutics Stock Plummeting On Monday?
June 17, 2024
From Benzinga
From Benzinga
Marinus Pharmaceuticals Shares Mixed Results From IV Formulated Ganaxolone In Pretreated Seizure Patients
June 17, 2024
From Benzinga
What's Going On With Ovid Therapeutics After Takeda's Two Phase 3 Epilepsy Studies Fail?
June 17, 2024
From Benzinga
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.